baber/WOPTO huggingface dataset:
Patent AU-2004241254-B2 (AU)
Title: Process for preparing UV curable sealing assemblies
Inventor: GOTTLIEB MARK BERNARD
IPC: B29C71/04
Filed: 2004-05-14
Granted: 2009-10-29
Abstract: Processes for preparation of seals and gaskets using cure-in-place techniques that incorporate a molding step, which is preferably an injection molding step, are provided. The processes are useful for preparing sealing assemblies that comprise compositions that are curable by UV radiation and that are adhered to a support member.
Patent AU-2004245739-B2 (AU)
Title: Screen for novel protein inhibitors based upon engineered cell line containing an inducible overactivity gene and compensatory gene
Inventor: FOSSUM SOLVEIG
IPC: C12Q1/18
Filed: 2004-06-03
Granted: 2009-04-23
Abstract: The present invention provides a method for identifying the presence of a protein inhibitor of a target protein in a sample, comprising the steps of a) contacting said sample with a cell, wherein said cell contains i) an inducible lethal overactivity mutation in a gene affecting the target protein; and ii) a mutation in a second gene, wherein the activity of the target protein is essential to the cell and the mutation in the second gene functionally compensates for any reduction in the activity of the target protein; b) inducing the lethal overactivity mutation; and subsequently c) assessing protein inhibition by comparing the degree of survival of the cell in the presence and the absence of said sample. Also provided are cells for use in said method.
Patent AU-2004290965-B2 (AU)
Title: Therapeutic foam
Inventor: HODGES GARRY
IPC: A61K9/12
Filed: 2004-11-17
Granted: 2011-04-28
Abstract: A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurized canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimizing the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed.
Patent AU-2004306243-B2 (AU)
Title: Method and system for providing a secure communication between communication networks
Inventor: NIEMI VALTTERI
IPC: H04L29/12
Filed: 2004-09-27
Granted: 2010-03-18
Abstract: A method of communication between a calling party in a first network and a called party in a second network is disclosed. The method comprises determining in the first network an address associated with the called party. The method also comprises determining, based on the address, if the called party is in a trusted network, and controlling the communication between the called party and the calling party in dependence on if the called party is in a trusted network.
Patent AU-2005202195-B2 (AU)
Title: Composition for colouring of keratin fibres
Inventor: NOCKER BERND
IPC: A61Q5/10
Filed: 2005-05-20
Granted: 2010-06-17
Abstract: Present invention is about coloring composition for keratin fibers especially human hair comprising  a- at least one oxidation dyestuff precursor reacting with peroxide, which is selected from tetraaminopyrimidines, triaminohydroxypyrimidines, diamino mono- and -di-hydroxy-pyrimidines and/or aminotriazines or water-soluble salts thereof, b- at least one acidic direct dye, and c- at least one cationic direct dye selected from the compounds presented with the general formulas III, IV, V and VI <CHEM> <CHEM> and <CHEM>  wherein R9, R10, R11 and R12 stand for hydrogen, a CH3- or C2H5- group, R13 stands for hydrogen, -OCH3 or -OC2H5 and Y is an anion such as chloride, bromide, methosulfate.
Patent AU-2005247887-B2 (AU)
Title: Recycling 2,6-naphthalenedicarboxylic acid (2,6-NDA) contained in polyethylene naphthalate in a process to produce diesters
Inventor: MOSSMAN ALLEN B
IPC: C07C67/03
Filed: 2005-05-09
Granted: 2010-09-09
Abstract: A process for preparing a dialkylester of a naphthalenedicarboxylic acid comprising directing a liquid phase reaction mixture comprising a low molecular weight alcohol, a naphthalenedicarboxylic acid, a dialkylester of a naphthalenedicarboxylic acid, and a polyethylene naphthalate containing material, at a given temperature and pressure through series arranged reaction zones and subsequently removing a product comprising a dialkylester formed by the reaction of the naphthalenedicarboxylic acid and the polyethylene naphthalate containing material with the low molecular weight alcohol from a reaction zone. This invention is also directed to a process for preparing a purified dialkylester of a naphthalenedicarboxylic acid comprising a series of crystallization and distillation steps, and combinations thereof.
Patent AU-2005287872-B2 (AU)
Title: Multipotential expanded mesenchymal precursor cell progeny (MEMP) and uses thereof
Inventor: STAN GRONTHOS
IPC: C12N5/077
Filed: 2005-09-26
Granted: 2011-06-23
Abstract: The invention relates to multipotential expanded mesenchymal precursor progeny (MEMP 's), characterised by the early developmental markers STRO-l and ALP. The present invention also relates to methods for producing MEMP's and to uses of MEMP's for therapeutic applications.
Patent AU-2005290844-B2 (AU)
Title: Compounds that Modulate TRH Actions and Inhibit the TRH-Degrading Enzyme
Inventor: JULIE KELLY
IPC: A61P25/00
Filed: 2005-10-03
Granted: 2011-09-29
Abstract: The invention relates to compounds that inhibit thyrotropin-releasing hormone (TRH)- degrading ectoenzyme and/or enhance, and/or mimic the biological actions of TRH. The compounds find therapeutic application, particularly in conditions involving neuronal cell injury and disturbances in neurobiological function. These compounds are based on a C-terminally extended TRH-structure, wherein the C-terminal extension mainly consists of (D) amino acids.
Patent AU-2005321898-B2 (AU)
Title: Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
Inventor: CHIANG CHIH-SHENG
IPC: A61K39/00
Filed: 2005-12-29
Granted: 2012-07-19
Abstract: Disclosed herein are methods and compositions for inducing an immune response against various combinations of tumor-associated antigens, which can promote effective immunologic intervention in pathogenic processes. Embodiments of the invention disclosed herein are directed to the use of effective combinations of TuAAs for the immunotherapy of patients with various types of cancer. Both immunogenic compositions for inducing an immune response to these combinations of antigens and methods for their use are disclosed.
Patent AU-2006204787-B2 (AU)
Title: Perfusion and/or preservation solution for organs
Inventor: YOUNG LINDON H
IPC: C12N5/071
Filed: 2006-01-13
Granted: 2012-07-05
Abstract: The present invention relates to a solution for preservation, perfusion, and/or reperfusion of an organ, especially the heart, for transplantation. The solution contains peptide inhibitor(s) of protein kinase C βII (PKC βII) and/or of protein kinase C ζ (PKC ζ) and/or peptide activator(s) of protein kinase C δ (PKCδ). Methods for using the inventive solution are also disclosed, including methods for preserving an organ for transplantation, for protecting an ischemic organ from damage, for attenuating organ dysfunction after ischemia, for maintaining nitric oxide release and/or inhibiting superoxide release in an ischemic organ, and for protecting an organ from damage when isolated from the circulatory system.
Patent AU-2006214325-B2 (AU)
Title: Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
Inventor: LEUNG DONALD Y M
IPC: C07K14/715
Filed: 2006-02-14
Granted: 2012-04-05
Abstract: The present invention relates to methods of treating patients suffering from itching and puritis mediated by cutaneous lymphocyte antigen positive T cell. In particular, diseases or disorders including contact dermatitis, drug induced delayed type cutaneous allergic reactions, toxic epidermal necrolysis, cutaneous T cell lymphoma, bullous pemphigoid, alopecia aereata, vitiligo, acne rosacea, prurigo nodularis, and herpes simplex virus, or combination thereof will benefit from the administration of an IL-31 antagonist. The invention also includes methods of predicting a therapeutically responsive patient population.
Patent AU-2006216567-B2 (AU)
Title: Methods for treating ocular angiogenesis, retinal edema, retinal ischemia, and diabetic retinopathy using selective RTK inhibitors
Inventor: BINGAMAN DAVID P
IPC: A61K31/00
Filed: 2006-02-23
Granted: 2011-10-13
Abstract: The present invention provides compositions and methods for treating ocular neovascularization, angiogenesis, retinal edema, diabetic retinopathy, and/or retinal ischemia in order to prevent the loss of visual acuity associated with such conditions. More specifically, the present invention provides compositions containing receptor tyrosine kinase (RTK) inhibitors having unique binding profiles and their use in treating ocular disorders.
Patent AU-2006225069-B2 (AU)
Title: Auto retractable syringe
Inventor: WALTON GRAEME FRANCIS
IPC: A61M5/50
Filed: 2006-03-14
Granted: 2013-02-21
Abstract: An auto-retractable safety syringe comprising a syringe barrel (12) having a hollow plunger (13) slideably located therein. The needle assembly comprises a needle and a needle hub (17), with a groove in the end of the barrel (12) to hold the needle hub (17) and a spring disposed over said needle hub (17) and acting between the needle hub (17) and the end of the barrel (12). The needle hub (17) has a groove around its circumference in which a locking means mates so as to retain the needle hub (17) in the end of the syringe barrel (12) during use. The plunger (13) upon completion of an injection and when further depressed activates auto retraction of the needle hub (17) by dislodging said locking means from said groove to release the needle hub (17) hence allowing the needle and spring to retract inside the hollow plunger (13) under the influence of the spring.
Patent AU-2006226084-B2 (AU)
Title: 2,3-substituted fused pyrimidin-4(3H)-ones as VR1 antagonists
Inventor: BAYLISS TRACY
IPC: C07D471/04
Filed: 2006-03-21
Granted: 2011-09-08
Abstract: A compound of formula (I), wherein W is formula (1); A is a benzene ring, a fÊve-membered heteroaromatic ring containing 1, 2 or 3 heteroatoms independently chosen from O, N and S, providing that no more than one O or S atom is present, or a six- membered heteroaromatic ring containing 1, 2 or 3 N atoms; n is zero, one, two or three; when n is zero or one, V is CH; when n is two or three, V is CH, O or NR; when V is CH2, the bond formed by V and an adjacent carbon ring atom is optionally fused to a phenyl ring, a five-membered heteroaromatic ring containing 1, 2 or 3 heteroatoms independently chosen from O, N and S, providing that no more than one O or S is present, or a six-membered heteroaromatic ring containing 1, 2 or 3 N atoms; the ring being optionally substituted by one or more R groups; and R and R are independently hydrogen, hydroxy, halogen or Calkyl; Z is a phenyl ring, a five-membered heteroaromatic ring containing one, two, three or four heteroatoms independently chosen from O, N or S, at most one heteroatom being O or S, or a six- membered heteroaromatic ring containing one, two or three N atoms, optionally substituted by one or more groups chosen from halogen, hydroxy, cyano, nitro, NRR or S(O)NRR where NRR is as defined above, Calkyl, Calkenyl, Calkynyl, haloCalkyl, Calkoxy, haloCalkoxy, Calkylthio, haloCalkylthio,Ccycloalkyl, hydroxyCalkyl, a five-membered heteroaromatic ring containing 1, 2or 3 heteroatoms independently chosen from O, N and S, providing that no more than one O or S atom is present, or a six-membered heteroaromatic ring containing 1, 2 or 3 N atoms; or a pharmaceutically acceptable salt or N-oxide thereof; pharmaceutical compositions comprising them; the compounds for use in methods of treatment; and use of the compounds for manufacturing medicaments for treating pain as VRl antagonists, including conditions such as depression, GERD, itch and urinary incontinence.
Patent AU-2006252297-B2 (AU)
Title: Pick up head for a product transfer device and method for transferring products
Inventor: GUIDETTI DARIO
IPC: B65D85/60
Filed: 2006-12-29
Granted: 2011-02-17
Abstract: Described herein is a pick-up head for a device for transferring products, in particular for an automatic packaging line, comprising: 
- a basic structure (12) equipped with an attachment flange (14) for its connection to a mobile part of the transfer device; and 
- a plurality of devices for picking up products (36), each of which is configured for picking up one or more products.  Each of said pick-up devices (36) is equipped with an independent power drive that is numerically controlled and can be displaced along the basic structure (12) either independently or jointly with respect to the other pick-up devices (36).
Patent AU-2006276861-B2 (AU)
Title: Multi-component end member assembly and air spring assembly including the same
Inventor: ROBERT TAYLOR
IPC: F16F9/04
Filed: 2006-06-28
Granted: 2011-11-17
Abstract: An end member assembly (102) includes a first end member (110) and a second end member (112). An air spring assembly (100) can be formed using an end member assembly on one end thereof. A method is also described.
Patent AU-2006299641-B2 (AU)
Title: Reactive surfaces, substrates and methods for producing and using same
Inventor: ROITMAN DANIEL BERNARDO
IPC: C12N11/14
Filed: 2006-09-29
Granted: 2012-02-02
Abstract: Reactive surfaces, substrates and methods of producing and using such substrates and surfaces are provided. The substrates and surfaces provide low density reactive groups preferably on an otherwise non-reactive surface for use in different applications including single molecule analyses.
Patent AU-2006334721-B2 (AU)
Title: Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths
Inventor: MICHAEL CZECH
IPC: A61P35/00
Filed: 2006-11-10
Granted: 2011-08-11
Abstract: The invention relates to novel pyridopyrazine compounds which are suited for the treatment or prevention of physiological and/or pathophysiological conditions in mammals, especially humans, transmitted and/or modulated by signal transduction paths and/or enzymes.
Patent AU-2007212489-B2 (AU)
Title: Methods and systems for reducing burst usage of a networked computer system
Inventor: SUSSMAN ADAM
IPC: G06F15/173
Filed: 2007-02-06
Granted: 2013-01-31
Abstract: Methods and systems for reducing burst usage of a networked computer system are described herein. In an embodiment, resource requesters can request, within a time window, resources over a computer network before the resources are available. The resources can then be allocated in batch mode when the resources are available. Thus, resource requests do not have to be processed in real-time, and resource requests can be received before the resources are available.
Patent AU-2007216223-B2 (AU)
Title: Process for over-production of hydrogen
Inventor: PANDEY BANIBRATA
IPC: C12M1/107
Filed: 2007-02-13
Granted: 2013-10-24
Abstract: The present invention provides a process of increasing production of hydrogen during fermentation process and also an electro-biochemical is designed to achieve higher hydrogen production.
Patent AU-2007234343-B2 (AU)
Title: Method for purifying silicon
Inventor: SCOTT NICHOL
IPC: C30B29/06
Filed: 2007-04-04
Granted: 2011-10-06
Abstract: The present invention provides for methods of purifying silicon, methods for obtaining purified silicon, as well as methods for obtaining purified silicon crystals, purified granulized silicon and/or purified silicon ingots.
Patent AU-2007319472-B2 (AU)
Title: Methods Of Administering Weight Loss Medications
Inventor: WEBER ECKARD
IPC: A61K9/20
Filed: 2007-11-08
Granted: 2013-01-17
Abstract: Methods and systems for administration of pharmaceuticals using a unit dosage package that includes a first unit dosage that has a first drug and a second drug, a second unit dosage that has the first drug and the second drug, where the second unit dosage includes a different amount of the second drug than the first unit dosage and a unit dosage package is configured to hold the first unit dosage and the second unit dosage. In preferred embodiments the methods and systems are used for administration of weight loss medications.
Patent AU-2007331723-B2 (AU)
Title: 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides
Inventor: SCUTT JAMES NICHOLAS
IPC: C07D311/96
Filed: 2007-12-12
Granted: 2013-05-30
Abstract: Pyrandione, thiopyrandione and cyclohexanetrione compounds, which are suitable for use as herbicides.
Patent AU-2007346673-B2 (AU)
Title: A forced air warming unit
Inventor: ZIAIMEHR ALLEN HAMID
IPC: A61F7/02
Filed: 2007-10-09
Granted: 2013-07-04
Abstract: Both the flow rate and the temperature of the air exiting a forced air warming unit are regulated in response to a single act or operation of a single element of control on a manually-operated remote control.
Patent AU-2008203011-B2 (AU)
Title: Microbicidal composition
Inventor: EL A MMA BEVERLY JEAN
IPC: A01N43/72
Filed: 2008-07-08
Granted: 2014-02-20
Abstract: Synergistic microbicidal compositions containing N-methyl- 1,2 benzisothiazolin -3-one.
Patent AU-2008207447-B2 (AU)
Title: Clamp
Inventor: LOUVAIN-WALTERS PAUL
IPC: E21B17/01
Filed: 2008-08-21
Granted: 2013-11-28
Abstract: A clamp is disclosed which is for mounting upon a cylindrical member such as a sub-sea riser or umbilical (12). The clamp has a set of outer clamp shells (14) shaped to be 5 arranged around the cylindrical member (12), and preferably adapted to be secured to one another in this configuration e.g. by means of bolts (16). Within the structure thus formed are inner clamp members (24) shaped to seat upon the cylindrical member e.g. through part-circular inner faces. The inner clamp members are biased into engagement with the cylindrical member by means of spring elements (20) pre-stressed upon 10 assembly of the clamp between opposed surfaces of the respective outer clamp shell and inner clamp member. Preferably, the spring elements (20) each act along a circumferential direction. Cl C0 '
Patent AU-2008214200-B2 (AU)
Title: Device, system and method for delivering a curable material into bone
Inventor: LINDERMAN EVAN D
IPC: A61B17/88
Filed: 2008-02-08
Granted: 2012-07-26
Abstract: A curable material delivery cannula device (25) is disclosed. The device includes a cannula and a hub. The cannula includes an open proximal end, a deflectable segment (88) forming a pre-set curve, a lumen, and side orifice (s) (84) adjacent, and proximally spaced from, the distal end and fluidly connected to the lumen. When inserted within a guide cannula, the deflectable segment straightens. When distally extended from the guide cannula, the deflectable segment reverts to the curved shape. The distal end has a blunt tip for non-traumatic interface with bodily material. During use, curable material, such as bone cement, is delivered from the side orifice (s) in a radial direction relative to the lumen.
Patent AU-2008235393-B2 (AU)
Title: Chain saw provided with a lubrication device and method implemented for performing said lubrication
Inventor: PELLENC ROGER
IPC: F16N29/02
Filed: 2008-02-25
Granted: 2013-11-07
Abstract: Chain saw comprising an endless cutting chain (5) fitted rotatably on a drive pinion and on a chain guide (6) equipped with a guiding rail, a motor for driving (8) said cutting chain, by means of said pinion, a storage tank (11) for a lubrication liquid, and a pump (13) for impelling the lubrication liquid towards the chain guide/cutting chain assembly (5-6), from the storage tank (10), characterised in that said pump (13) is coupled to an electric drive motor (13a) which is independent of the cutting chain (5) drive motor (8).
Patent AU-2008257130-B2 (AU)
Title: Impermeable capsules
Inventor: SHIRA PILCH
IPC: A61K8/11
Filed: 2008-04-30
Granted: 2011-07-14
Abstract: A capsule comprising a core and a shell surrounding and enclosing the core, the shell comprising at least one first polymer having a first water solubility parameter, and at least one second polymer having a water solubility parameter higher than the first water solubility parameter, wherein the second polymer is crosslinked, and/or all of the at least one second polymer is present in an amount that is less than all of the at least one first polymer. Upon exposure to an aqueous medium, the first polymer begins to swell, and water begins to leak into the capsule. Also, the second polymer is attracted to the entering water. As the second polymer absorbs water and swells, the mean free space in the shell decreases and the tortuous pathway for materials crossing the boundary of the wall increases. As a result, leakage rates across the capsule wall decrease.
Patent AU-2008275679-B2 (AU)
Title: Human disc tissue
Inventor: KUKEKEOV VALERY
IPC: A61K35/12
Filed: 2008-07-07
Granted: 2014-10-09
Abstract: This invention provides an isolated disc stem cell population, compositions, and methods of obtaining and growing the same. Moreover, this invention provides an isolated discosphere, compositions, and methods of obtaining and growing the same. An artificial disc containing the cells of the present invention is provided together with methods of making the same. This invention also provides a method of treating a subject having a herniated disc utilizing the cells and methods of the invention.
Patent AU-2008286194-B2 (AU)
Title: Impedance measurement process
Inventor: THOMAS BRIAN JOHN
IPC: A61B5/296
Filed: 2008-08-07
Granted: 2014-05-15
Abstract: A method for use in performing impedance measurements on a subject. The method includes, in a processing system, determining at least one first impedance value, measured at a site using a first electrode configuration, determining at least one second impedance value, measured at the site using a second electrode configuration, and determining the presence, absence or degree of an anomaly using the first and second impedance values.
Patent AU-2008297316-B2 (AU)
Title: Continuous production of polyurethanes/polyureas
Inventor: MACK HELMUT
IPC: B01J19/18
Filed: 2008-09-01
Granted: 2013-02-07
Abstract: The invention relates to a continuous method for producing polyurethanes/polyureas by applying the components of a starting reaction composition individually and/or as a mixture onto an inner region of a hot surface of a rotating body A in the form of a thin film so that the thin film flows across the hot surface of the rotating body A towards an outer region of the hot surface of the rotating body A, the thin film leaving the hot surface as a reaction composition containing polyurethanes/polyurea and the reaction composition being suddenly cooled after leaving the hot surface. The components of the starting reaction composition are a polyisocyanate component and a polyol/polyamine component, the temperature of the hot surface is 70 to 400°C and the sudden cooling of the reaction composition is at least 30°C.